Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Low-Dose BRAF-Inhibitors in the Treatment of Histiocytic Disorders with the BRAF-V600E Mutation

Gordon Ruan, MD, Gaurav Goyal, MBBS, Jithma P. Abeykoon, MD, N. Nora Bennani, MD, Karen Rech, MD, Jason Young, MD, Mithun Vinod Shah, MD PhD, Ronald S. Go, MD

Blood (2019) 134 (Supplement_1): 5895.

https://doi.org/10.1182/blood-2019-124891

Published: 2019

Journal Articles

Comparative Risk Assessment of Imatinib, Nilotinib and Dasatinib in Randomized Controlled Trials: A Meta-Analysis

Ahmad Ghorab, MDMSc, Hagop M. Kantarjian, MD, Hesham Elhalawani, MD MS, Hoda Ahmed, MD MS, Ahmed Essam, MD, Omar Abdel-Rahman, MD PhD, Elias J. Jabbour, MD, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 2869.

https://doi.org/10.1182/blood.V130.Suppl_1.2869.2869

Published: 2017

Journal Articles

A Randomized Phase 2 Placebo Controlled Trial of Clobetasol Rinse for Treatment of Oral Chronic Graft-Versus-Host Disease

Jacqueline W. Mays, DDS, MHSc, PhD, Lauren M. Curtis, MD, Carol Bassim, DMD, MS, Seth M. Steinberg, PhD, David Venzon, PhD, Jeremy J. Rose, MS, Monica Cho, Christopher G. Kanakry, MD, Fahd Yazdanie, Daniele Avila, NP, Kristin Baird, MD, Jennifer Hsu, RN, Licia Masuch, George Grimes, RPh, Judith Starling, RPh, Daniel H. Fowler, MD, Ronald E. Gress, MD, Fran T. Hakim, PhD, Steven Z. Pavletic, MD

Blood (2016) 128 (22): 826.

https://doi.org/10.1182/blood.V128.22.826.826

Published: 2016

Journal Articles

Dasatinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP) with Persistent, Low-Grade Nonhematologic Toxicity to Imatinib: Results from Dasperse (CA180-400)

Dong-Wook Kim, Charles S. Cleeland, PhD, Susanne Saussele, Loretta A. Williams, PhD APRN, Hesham Mohamed, Javier Pinilla-Ibarz, Elisabetta Abruzzese, MD

Blood (2015) 126 (23): 1575.

https://doi.org/10.1182/blood.V126.23.1575.1575

Published: 2015

Journal Articles

Clinical Characteristics of Rituximab Intolerance in Patients with Waldenstrom's Macroglobulinemia

Sandra Kanan, NP, Kirsten Meid, MPH, Steven P Treon, MD MA, PhD, Jorge J. Castillo, MD

Blood (2014) 124 (21): 2610.

https://doi.org/10.1182/blood.V124.21.2610.2610

Published: 2014

Journal Articles

Phase 1b Dose-Escalation Study of Sonidegib (LDE225) in Combination with Ruxolitinib (INC424) in Patients with Myelofibrosis

Vikas Gupta, MD FRCP, FRCPath, Steffen Koschmieder, MD, Claire N. Harrison, DM, FRCP, FRCPath, Francisco Cervantes, MD PhD, Florian H Heidel, MD, Mark Drummond, MD PhD, Jerome Rey, MD, Eunju Hurh, PhD, Weichao Bao, PhD, Anita Rampersad, Stacey Kalambakas, MD, Alessandro Maria Vannucchi, MD

Blood (2014) 124 (21): 712.

https://doi.org/10.1182/blood.V124.21.712.712

Published: 2014

Journal Articles

Isolated Granulocytic Sarcoma Of The Nasopharynx: A Case Report and Review Of The Literature

Ravindra Reddy Chuda, MD, Prakash Vishnu, MD, FACP, Dick Hwang, MD, Ph.D, David M. Aboulafia, MD

Blood (2013) 122 (21): 5010.

https://doi.org/10.1182/blood.V122.21.5010.5010

Published: 2013

Journal Articles

Subcutaneous panniculitis-like T-cell lymphoma presented with full facial edema, hemophagocytic syndrome and Epstein-Barr Virus infection:A case report

Lin Li, MD, PhD, Jianyi Chen, Bing Zhang, Xuejun Zhu, Xuemei Sun, MD, PhD

Blood (2013) 122 (21): 5074.

https://doi.org/10.1182/blood.V122.21.5074.5074

Published: 2013

Journal Articles

Safety and Efficacy Of Obinutuzumab (GA101) With Fludarabine/Cyclophosphamide (G-FC) Or Bendamustine (G-B) In The Initial Therapy Of Patients With Chronic Lymphocytic Leukemia (CLL): Results From The Phase 1b Galton Trial (GAO4779g)

Jennifer R Brown, MD, PhD, Susan O'Brien, MD, C Daniel Kingsley, MD, FACP, Herbert Eradat, MS, MD, John M. Pagel, MD, PhD, James Lymp, PhD, Jamie Hirata, PharmD, Thomas J. Kipps, MD, PhD

Blood (2013) 122 (21): 523.

https://doi.org/10.1182/blood.V122.21.523.523

Published: 2013

Journal Articles

Successful Tolerance of Deferasirox Following Desensitization for Significant Skin Rash

Hatoon Ezzat, MBBS, FRCP, ABIM, R. Robert Schellenberg, Heather A Leitch, MD, PhD, FRCPC, Linda M Vickars, MD, FRCP(C)

Blood (2011) 118 (21): 5280.

https://doi.org/10.1182/blood.V118.21.5280.5280

Published: 2011

Journal Articles

A Phase II Study of the MEK 1/2 Inhibitor AZD6244 (Selumetinib, ARRY-142866) in Relapsed or Refractory Multiple Myeloma

Beata Holkova, MD, Ashraf Z. Badros, MD, Robert Geller, MD, Peter M. Voorhees, MD, Adriana Zingone, MD, PhD, Neha Korde, MD, Hui-Yi Lin, PhD, Mary Beth Tombes, RN, Ellen Shrader, Heidi Sankala, PhD, Maciej Kmieciak, PhD, John D. Roberts, MD, Daniel Sullivan, MD, Ola Landgren, MD, PhD, Steven Grant, MD

Blood (2011) 118 (21): 2931.

https://doi.org/10.1182/blood.V118.21.2931.2931

Published: 2011

Journal Articles

Dasatinib Compared with Imatinib In Newly Diagnosed Chronic Myelogenous Leukemia In Chronic Phase (CML-CP):Results of Japanese Subset Analysis In DASISION Trial.

Michinori Ogura, MD, PhD, Hirohisa Nakamae, MD, PhD, Shin Fujisawa, MD, PhD, Kenichi Ishizawa, MD, Masafumi Taniwaki, MD, PhD, Atae Utsunomiya, MD, PhD, Kosei Matsue, MD, PhD, Kazuo Tamura, MD, Kensuke Usuki, MD, PhD, Mitsune Tanimoto, MD, PhD, Yoji Ishida, MD, PhD, Hideki Akiyama, MD, PhD, Rika Sakai, MD, PhD, Masanobu Kasai, MD, PhD, Masayuki Hino, MD, PhD, Kyoji Ueda, MD, PhD, Taku Seriu, MD, PhD, M. Brigid Bradley-Garelik, MD, Chao Zhu, PhD

Blood (2010) 116 (21): 4484.

https://doi.org/10.1182/blood.V116.21.4484.4484

Published: 2010

Journal Articles

Massive Pleural Effusions and Anasarca After Allogeneic Hematopoietic Cell Transplantation.

Baldeep Wirk, MD

Blood (2010) 116 (21): 4556.

https://doi.org/10.1182/blood.V116.21.4556.4556

Published: 2010

Journal Articles

Accidental and Intentional Overdose of Imatinib: a Report of Outcome and Side Effect of 46 Cases.

François Guilhot, MD, Alan K. Hatfield, MD, FACP, Frederic Millot, Lydia Roy, Mathieu Molimard, Jean Cui

Blood (2009) 114 (22): 4273.

https://doi.org/10.1182/blood.V114.22.4273.4273

Published: 2009

Journal Articles

Extranodal NK/T-Cell Lymphoma, Nasal Type: Experience of Management in a Referral Hospital in a Development Country.

Humberto Castellanos-Sinco, MD, Silvia Rivas-Vera, MD, Victoria E. Ferrer Argote, MD, Christian Omar Ramos Peñafiel, MD, Ana Carmen Salinas-Torres, MD, Angélica Romo-Jiménez, MD, Merit Hernández-Sánchez, MD, Carlos Martínez-Murillo, MD

Blood (2009) 114 (22): 4767.

https://doi.org/10.1182/blood.V114.22.4767.4767

Published: 2009

Journal Articles

Intravenous Iron Sucrose for Children with Iron Deficiency and/or Gastrointestinal Hemorrhage.

Katherine Hall, BS, Shelley E. Crary, MD, MSCS

Blood (2009) 114 (22): 2006.

https://doi.org/10.1182/blood.V114.22.2006.2006

Published: 2009

Journal Articles

An Expanded Post-Thrombosis Sequelae Assessment Scale in Children.

Anjali A. Sharathkumar, MD, Dave Van Mater, MD,PhD, Derek Demscheff, PhD, Steven W. Pipe, MD

Blood (2007) 110 (11): 3196.

https://doi.org/10.1182/blood.V110.11.3196.3196

Published: 2007

Journal Articles

Primary Oral Cavity Lymphomas. Features of 29 Patients Assisted at Oncology Hospital Marie Curie, Buenos Aires Argentina.

Marta O. Dragosky, MD, Nelly Frascino, Susana Alcaraz, MD, Isabel Annetta, MD, Laura Devoto, MD, Patricia Luchetta, MD, Marisa Marquez, MD, Carmen Giaco, Karina Gallo, Gabriela Acosta, MD, Elsa Alcoba, MD, Jorgelina Stagnaro, MD, Laura Guerrero, MD

Blood (2006) 108 (11): 4617.

https://doi.org/10.1182/blood.V108.11.4617.4617

Published: 2006

Journal Articles

A Phase II Study of Dasatinib in Patients with Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis or Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Who Are Resistant or Intolerant to Imatinib: The ‘START-L’ CA180015 Study.

Oliver G. Ottmann, G. Martinelli, H. Dombret, H. Kantarjian, A. Hochhaus, B. Simonsson, A. Aloe, A. Apanovitch, N. Shah

Blood (2005) 106 (11): 42.

https://doi.org/10.1182/blood.V106.11.42.42

Published: 2005

Journal Articles

The Feasibility of High-Dose Dexamethasone (HD-DEX) in Idiopathic Thrombocytopenic Purpura (ITP) in Adults; a Multi-Center Study in Korea.

Yeo-Kyeoung Kim, Je-Jung Lee, Moo-Rim Park, Sung-Hwa Bae, Hyo Jung Kim, Seok Jung Kim, Deok-Hwan Yang, Byung Soo Kim, Hyeoung-Joon Kim, Chul Won Choi

Blood (2005) 106 (11): 4009.

https://doi.org/10.1182/blood.V106.11.4009.4009

Published: 2005

NARROW

Low-Dose BRAF-Inhibitors in the Treatment of Histiocytic Disorders with the BRAF-V600E Mutation

Comparative Risk Assessment of Imatinib, Nilotinib and Dasatinib in Randomized Controlled Trials: A Meta-Analysis

A Randomized Phase 2 Placebo Controlled Trial of Clobetasol Rinse for Treatment of Oral Chronic Graft-Versus-Host Disease

Dasatinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP) with Persistent, Low-Grade Nonhematologic Toxicity to Imatinib: Results from Dasperse (CA180-400)

Clinical Characteristics of Rituximab Intolerance in Patients with Waldenstrom's Macroglobulinemia

Phase 1b Dose-Escalation Study of Sonidegib (LDE225) in Combination with Ruxolitinib (INC424) in Patients with Myelofibrosis

Isolated Granulocytic Sarcoma Of The Nasopharynx: A Case Report and Review Of The Literature

Subcutaneous panniculitis-like T-cell lymphoma presented with full facial edema, hemophagocytic syndrome and Epstein-Barr Virus infection:A case report

Safety and Efficacy Of Obinutuzumab (GA101) With Fludarabine/Cyclophosphamide (G-FC) Or Bendamustine (G-B) In The Initial Therapy Of Patients With Chronic Lymphocytic Leukemia (CLL): Results From The Phase 1b Galton Trial (GAO4779g)

Successful Tolerance of Deferasirox Following Desensitization for Significant Skin Rash

A Phase II Study of the MEK 1/2 Inhibitor AZD6244 (Selumetinib, ARRY-142866) in Relapsed or Refractory Multiple Myeloma

Dasatinib Compared with Imatinib In Newly Diagnosed Chronic Myelogenous Leukemia In Chronic Phase (CML-CP):Results of Japanese Subset Analysis In DASISION Trial.

Massive Pleural Effusions and Anasarca After Allogeneic Hematopoietic Cell Transplantation.

Accidental and Intentional Overdose of Imatinib: a Report of Outcome and Side Effect of 46 Cases.

Extranodal NK/T-Cell Lymphoma, Nasal Type: Experience of Management in a Referral Hospital in a Development Country.

Intravenous Iron Sucrose for Children with Iron Deficiency and/or Gastrointestinal Hemorrhage.

An Expanded Post-Thrombosis Sequelae Assessment Scale in Children.

Primary Oral Cavity Lymphomas. Features of 29 Patients Assisted at Oncology Hospital Marie Curie, Buenos Aires Argentina.

A Phase II Study of Dasatinib in Patients with Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis or Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Who Are Resistant or Intolerant to Imatinib: The ‘START-L’ CA180015 Study.

The Feasibility of High-Dose Dexamethasone (HD-DEX) in Idiopathic Thrombocytopenic Purpura (ITP) in Adults; a Multi-Center Study in Korea.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only